2011 QMT Catalog

TM
Every
number
is a life.
TM
2 011 QUALITY
MANAGEMENT TOOLS
Q-PROBES In-Depth Quality Assessment Program
Q-TRACKS Continuous Quality Monitoring Program
LMIP Laboratory Management Index Program
CAP LINKS The Laboratory Integrated Knowledge Source
www.cap.org
Quality Management Tools

The CAPs comprehensive collection of Quality Management Tools (QMT) strengthens your
knowledge of key laboratory processes, identifies quality improvement opportunities, and
provides the information you need for effective laboratory management:
The CAPs Quality Management Tools help you:
Identify quality improvement opportunities and monitor progress over time
Establish realistic goals for your laboratory using a set of customized external benchmarks
Demonstrate the ability to meet accreditation requirements
Integrate QMT into your daily activities to support your quality improvement initiatives!
Approved for Maintenance of Certification

by the American Board of Pathology
Available in all Q-PROBES and Q-TRACKS programs
Quality Management
Tools
The CAPs comprehensive collection of Quality Management Tools (QMT) strengthens your
knowledge of key laboratory processes, identifies quality improvement opportunities, and
provides the information you need for effective laboratory management:

The CAPs Quality Management Tools help you:
Identify quality improvement opportunities and monitor progress over time

Establish realistic goals for your laboratory using a set of customized
external benchmarks
Demonstrate the ability to meet accreditation requirements
Integrate QMT into your daily activities to support your quality improvement initiatives!
2011 Quality Management Tools
www.cap.org 1
Q-PROBES and Q-TRACKS

Customer Satisfaction
Chemistry/Hematology
Transfusion Medicine
Microbiology
Patient Safety
Turnaround Time
Clinical Pathology
Postanalytic
Analytic
Preanalytic
Select Q-PROBES and

Q-TRACKS studies to
support your quality
improvement initiatives.
Anatomic Pathology
offer a comprehensive collection of tools to

complement your quality management program needs.*
Q-PROBES
Laboratory Services for Emergency

Department (QP111)
Appropriateness of Plasma Transfusions
(QP112)
Surgical Pathology Report Defects
(QP113)
Clinical Consequences of Specimen
Rejection (QP114)
Q-TRACKS
Patient Identification Accuracy (QT1)

Blood Culture Contamination (QT2)
In-Date Blood Product Wastage (QT4)

Gynecologic Cytology Outcomes:
Biopsy Correlation Performance (QT5)
Satisfaction with Outpatient Specimen
Collection (QT7)
Stat Test Turnaround Time Outliers (QT8)
Laboratory Specimen Acceptability (QT3)
Critical Values Reporting (QT10)
Corrected Results (QT16)
Outpatient Order Entry Errors (QT17)

Specimen Acceptability in Blood
Bank (QT18)
Turnaround Time of Troponin (QT15)
*The CAP requires accredited laboratories to have a quality management plan that covers all areas of the laboratory and includes
benchmarking key measures of laboratory performance (GEN.13806, 20316). The Joint Commission requires accredited hospitals to
regularly collect and analyze performance data (PI.01.01.01, PI.02.01.01). CLIA requires laboratories to monitor, assess, and correct
problems identified in preanalytic, analytic, and postanalytic systems (493.1249, 493.1289, 493.1299).
2 800-323-4040 Option 1 for Customer Contact Center
College of American Pathologists
Q-PROBES
Q-PROBES
A Program for In-depth Comprehensive Assessment
Evaluate quality improvements in your lab With todays focus on reducing medical
errors, laboratories strive to achieve and maintain excellence. Using short-term
studies, Q-PROBES provides a one-time comprehensive assessment of key processes
in your laboratory.
Structure your data collection and analysis for success Use Q-PROBES to help build
and improve data collection and analysis processes that contribute to quality of
care, patient safety, and outcomes.
Establish realistic laboratory benchmarks and performance goals Implement
Q-PROBES, an external peer-comparison program, to address process-, outcome-,
and structure-oriented quality assurance issues. Establish benchmarks through
external database comparisons and compare your performance to that of peer
organizations to establish laboratory goals and improve performance.
Q-PROBES offers CE credit to all laboratory staff to help you build a solid foundation
of education and knowledge within your organization.
Examine the effectiveness of key processes

with Q-PROBES.
www.cap.org 3
Q-PROBES
Laboratory Services for Emergency Department QP111
New
Optimal turnaround time (TAT) for testing is a critical element of laboratory service for the Emergency Department
(ED). TAT for laboratory testing may impact patient throughput in the ED, which, in turn, can then impact hospital bed
capacity management.
Laboratory TAT for key tests impacts workflow for ED physicians and staff as well as satisfaction of the ED pysicians with
laboratory services. As a result of TAT issues, the laboratory might expend additional resources for point-of-care (POC)
testing or satellite laboratories in the ED.
Objective
Laboratory TAT for key tests impacts workflow for ED physicians and staff as well as satisfaction of the ED physicians
Measure order-to-report TAT for laboratory tests frequently requested from the ED and measure the satisfaction of ED
with
physicians with the TAT provided.
laboratory services. As a result of TAT issues, the laboratory might expend additional resources for point-of-care (POC)
Data
Collection
testing
or satellite laboratories in the ED.
For a four-week period, participants will prospectively review specimens submitted to the laboratory for creatinine
and CBC testing and microscopic urinalysis. For each test type, participants will identify three specimens per day,
during the day shift, and record the times for test order, specimen collection, laboratory receipt, and result reports.
For specimens not collected by the laboratory and for which the order and collection times cannot be determined
electronically, participants may enlist the aid of ED personnel. POC testing is excluded from this study.
Participants will also send a questionnaire to ED physicians to determine the level of satisfaction with laboratory
services. Physicians may access and return the questionnaire to the laboratory in an electronic format.
Performance Indicators
Primary:
o Order-to-report TATs for creatinine, CBC, and microscopic urinalysis
Secondary:
o Satisfaction of ED physicians with clinical laboratory services
This is a one-time study conducted in the first quarter.
Q-PROBES
Appropriateness of Plasma Transfusions QP112
New
Blood products are a precious medical therapeutic resource with potential for significant adverse outcome, yet their
use does not always fall within accepted guidelines. Plasma transfusion is indicated for treatment of coagulopathies
due to insufficient clotting factors and replacement of single clotting factors for which specific concentrates are not
available. Hospital Transfusion Services and Transfusion/Blood Utilization Committees must track a variety of quality
indicators in order to meet accreditation guidelines. Appropriateness of plasma transfusion is a clinically relevant
indicator, with impact on patient safety as well as inventory and cost.
Objective
Assess the conformance of plasma transfusion practice to institutional guidelines and assess the post-transfusion
coagulation testing documentation and extent of coagulation correction achieved.
Data Collection
Participants will retrospectively review the records from 40 patients receiving plasma transfusion. For each patients
initial plasma transfusion episode during his or her admission, the clinical indication and recent pretransfusion
coagulation laboratory values will be recorded and evaluated for conformance with the facilitys own guidelines.
The study will require the examination of each patients post-transfusion record for documentation of
post-transfusion coagulation testing and the degree of coagulation correction achieved.
Primary:
o Rate of plasma transfusions that met institutional guidelines

o Rate of pre- and post-transfusion coagulation testing
Secondary:
o Rate of plasma units prepared but not transfused

o Rate of reported transfusion reactions
This is a one-time study conducted in the second quarter.
www.cap.org 5
Q-PROBES
Surgical Pathology Report Defects QP113
New
Amended surgical pathology reports convey new information or changes to diagnosis after a final report has been
issued. Report errors may cover a spectrum from the relatively innocuous (eg, the wrong clinicians name is on the
report or the patients age is incorrect) to serious errors that drastically affect patient management (eg, a malignant
lesion mistaken for benign). Report errors are often detected through passive means, such as clinician discovery,
patient discovery, case review for clinical conferences, or through mandatory case review at a tertiary treatment
center. Recent surveillance methods target more active means of detecting errors, such as double review of a
selected population of cases (eg, all new malignancies), double review of a set percentage of cases, and review of
written reports by ancillary personnel.
Objective
Examine the rate of report defects and the reasons for those defects, determine the means by which report defects
are discovered, and determine the effect of report defects on patient care.
Data Collection
Participants will conduct two data collections. The first will prospectively identify all forms of amended reports over a
period of 12 weeks, or until 50 amended reports have been reviewed, whichever comes first. For each case,
participants will determine the type of error present and how the error was discovered. The second data collection
will retrospectively identify amended reports that specifically involve diagnostic changes over a period of 12 months
or to a maximum of 10 amended reports, whichever comes first. For each case, participants will determine how the
error was discovered and the degree of diagnostic change.
Performance Indicator
Rate of surgical pathology report defects
Performance Breakdown
Breakdown of surgical pathology report defect reasons:

o
o
o
o
Misinterpretation
Misidentification
Specimen defects
Defects related to the report itself
This is a one-time study conducted in the third quarter.
Q-PROBES
Clinical Consequences of Specimen Rejection QP114
New
Specimen rejection may have significant consequences for patients and their clinical management. Patients whose
specimens are rejected are frequently subjected to repeat specimen collection, resulting in inconvenience, the
discomfort of repeat phlebotomy or other collection procedures, and/or the potential need for blood transfusion due
to excessive iatrogenic blood loss. Specimen rejection and the need for specimen correction or recollection also
ultimately lead to a delay in specimen analysis and the availability of test results.
Objective
Quantify the effect of laboratory specimen rejection on the delay in test result availability and determine the effect
on test result availability by: a) the reason for specimen rejection, b) the detection method for mislabeled
specimens, and c) the laboratorys policy regarding resolution of improperly labeled specimens.
Data Collection
Determine the number of blood and urine specimens received by the chemistry and hematology laboratory
sections to identify 80 rejected specimens or until you have reviewed specimens for six weeks, whichever comes first.
For each rejected specimen, record the following times: laboratory receipt, time specimen deemed unacceptable,
request time of specimen recollection, and time of recollected specimen receipt. Rejected specimens will be
categorized as improperly labeled or inappropriate or inadequate specimen.
This study excludes blood and urine specimens submitted for highly specialized testing, including flow cytometric,
molecular DNA or RNA, and/or cytogenetic analysis, as well as specimens for point-of-care testing.
Primary:
o Median specimen processing delay for all rejected chemistry and hematology blood specimens, regardless of
the reason for rejection
Secondary:
o Percentage of rejected chemistry and hematology blood specimens

o Percentage of corrected or redrawn chemistry and hematology blood specimens received
Breakdown of rejection reason for the two groups:

o Improperly labeled specimen
o Inappropriate or inadequate specimen
This is a one-time study conducted in the fourth quarter.
www.cap.org 7
Q-TRACKS
Q-TRACKS
A Program of Continuous Quality Monitoring
Observe performance trends over time to identify and monitor opportunities for quality improvement through
quantitative quality measures. Q-TRACKS offers continuous quality monitoring with longitudinal tracking of
performance and key indicators for clinical and anatomic pathology.
Step 1:
Establish realistic benchmarks by comparing

your laboratory to others like yours.
Q-TRACKS: QT3 - Laboratory Specimen Acceptability
External Comparison Report: January-March
Step 2:
Identify improvement opportunities.
(most like you)
Q-TRACKS: QT3 - Laboratory Specimen Acceptability

Trend Analysis Report: January-March
Step 3:
Monitor improvement over time to

ensure accurate diagnosis, patient
safety, and quality patient care.
Q-TRACKS offers CE credit for all laboratory staff each quarter to help you build a solid
foundation of education and knowledge within your organization.
Q-TRACKS
Q-TRACKS Clinical Pathology Monitors
Patient Identification Accuracy QT1
In order to report accurate laboratory results and meet The Joint Commission National Patient Safety Goal #1:
Improve the accuracy of patient identification, institutions must properly identify patients. Since most laboratories
perform testing away from the patient, patient identification, labeling of specimens, and coordination with test
requisitions must be performed accurately and completely. By continuously monitoring for wristband errors,
participants can promptly identify and correct problems that may interfere with patient care services.
Objective
Assess the incidence of wristband errors within individual institutions, compare performance between participating
institutions, and identify improvement opportunities.
Data Collection
On six predetermined days per month, participants will monitor patient wristband identification for all phlebotomies
performed at their institution. Phlebotomists will tally the total number of wristbands checked, the number of errors
found, and the types of wristband error. This monitor includes all routinely wristbanded patients. (Include emergency
department patients only if the emergency department routinely applies wristbands to these patients.)
Wristband Error Rate (%)
Breakdown of Wristband Error Types (%)
Blood Culture Contamination QT2
Despite advances in blood culture practices and technology, false-positive blood culture results due to contaminants
continue to be a critical problem. Blood culture contamination rate, the primary indicator of preanalytic
performance in microbiology is associated with increased length of hospital stay, additional expense, and the
administration of unnecessary antibiotics. The CAP and other accrediting organizations require you to monitor and
evaluate key indicators of quality for improvement opportunities. Use this monitor to help you meet this requirement.
Objective
Determine the rate of blood culture contamination using standardized criteria for classifying contaminants.
Data Collection
On a monthly basis, participants will tabulate the total number of blood cultures processed and the total number of
contaminated blood cultures. Blood cultures from neonatal patients are tabulated separately. For the purposes of
this study, participants will consider a blood culture to be contaminated if they find one or more of the following
organisms in only one of a series of blood culture specimens: Coagulase-negative Staphylococcus; Micrococcus;
Alpha-hemolytic (viridans) Streptococci; Propionibacterium acnes; Corynebacterium sp. (diptheroids); or Bacillus sp.
Participants have the option to monitor institution-specific subgroups.
Neonatal Contamination Rate (%)

Other Contamination Rate (%)
Overall Contamination Rate (%)
Look for your input forms approximately three weeks prior to the quarter.
www.cap.org 9
Q-TRACKS
Laboratory Specimen Acceptability QT3
A substantial amount of rework, diagnostic and therapeutic delay, and patient inconvenience can result from
specimen rejection. Patient redraws may result from unlabeled, mislabeled, and incompletely labeled specimens;
clotted and/or hemolyzed specimens; or insufficient specimen quantity. By continuously monitoring specimen
acceptability, collection, and transport, laboratories can promptly identify and correct problems. Participation in this
monitor can help satisfy the CAPs Checklist question GEN.20348, Are preanalytic processes monitored?
Objective
Identify and characterize unacceptable blood specimens that are submitted to the chemistry and hematology
sections of the clinical laboratory for testing.
Data Collection
This monitor includes all blood specimens submitted for testing to the chemistry and hematology departments of the
clinical laboratory. On a weekly basis, participants will record the total number of specimens received, the number
of rejected specimens, and the primary reason each specimen was rejected.
Specimen Rejection Rate (%)
Breakdown of Reasons for Rejection (%)
In-Date Blood Product Wastage QT4
Blood for transfusion is a precious resource. At a minimum, wastage of blood that is not out-of-date represents a
financial loss to the health care system. More ominously, systemic wastage of blood may reflect an environment of
care that is out of control and could pose risks to patient safety.
Objective
Compare the rates of blood product wastage (ie, units discarded in-date) in participating hospitals and track rates
of improvement over time.
Data Collection
On a monthly basis, participants will use blood bank records to obtain information on the total number of units
transfused for each type of blood component. Participants will track the number and type of blood units that are
wasted in-date and the circumstances of wastage. Include the following types of blood components: whole blood
(allogeneic); red blood cells (allogeneic); frozen plasma; platelet concentrates; single-donor platelets; and
cryoprecipitate.
Overall Blood Wastage Rate (%)

Wastage Rates by Blood Component Type (%)
Breakdown of Circumstances of Wastage (%)
Q-TRACKS
Satisfaction with Outpatient Specimen Collection QT7
Specimen collection is one of the few areas of laboratory medicine that involves direct outpatient contact. As a
result, patient satisfaction with this service is a vital indicator of quality laboratory performance. Accrediting agencies
such as The Joint Commission and CAP (GEN.20368) require measurement of patient satisfaction with laboratory
services. Use this monitor to help you meet this requirement.
Objective
Assess patient satisfaction with outpatient phlebotomy services by measuring patients assessment of waiting time,
discomfort level, courteous treatment, and overall satisfaction.
Data Collection
On a monthly basis, participants will distribute copies of a questionnaire to a minimum of 25 outpatients (maximum
of 99 outpatients), using predetermined data collection criteria. This monitor includes any outpatient undergoing
venipuncture. This monitor excludes patients seen in the emergency department, ambulatory surgery area, urgent
care facility, chest pain center, 23-hour short-stay facility, employee health department, outpatient health screening
fair/promotion, dialysis center, nursing home, or extended care facility.
Overall Patient Satisfaction Score

Patients More Than Satisfied (%)
Stat Test Turnaround Time Outliers QT8
The stat test turnaround time (TAT) outlier rate, expressed as a percentage of tests missing target reporting times, is a
measure of outcomes that evaluates how well the laboratory meets patient and clinician needs. This monitor helps
meet CAP Checklist question GEN.20316, Does the QM program include monitoring key indicators of quality?
Objective
Monitor the frequency with which stat test TAT intervals exceed institutional stat test TAT expectations.
Data Collection
Before beginning data collection, participants will establish a specimen receipt-to-report deadline for emergency
department (ED) stat potassium tests. On six predetermined days per month, participants will monitor the TAT of up to
10 randomly selected ED stat potassium tests on each of three eight-hour shifts (up to 180 tests per month) and track
the number of ED stat potassium determinations reported later than the established reporting deadline. This monitor
includes stat potassium tests ordered as part of a panel and excludes stat potassium levels that are requested on
body fluids other than blood, as part of timed or protocol studies, or after the specimen arrives in the laboratory.
Stat Test TAT Outlier Rate (%)
Performance Breakdowns
Breakdown of Outliers by Shift (%)

Breakdown of Outliers by Day of Week (%)
www.cap.org 11
Q-TRACKS
Critical Values Reporting QT10
Laboratories commonly refer to critical values as results requiring immediate notification to the physician or caregiver
for necessary patient evaluation or treatment. Recent regulations from agencies and accreditors such as CMS, The
Joint Commission, and the CAP (GEN.20316, 20365, 41320) mandate that laboratories develop and implement an
alert system for critical values. Use this monitor to document compliance with your laboratorys alert plan.
Objective
Evaluate the documentation of successful critical values reporting of general chemistry, hematology, and
coagulation analytes for both inpatients and outpatients according to the laboratorys policy.
Data Collection
On a monthly basis, participants will evaluate 120 inpatient and 120 outpatient critical values. Data collection will
include general chemistry, hematology, and coagulation analytes on the critical values list. Retrospectively,
participants will record the total number of critical values monitored and the number with documentation of
successful notification. This monitor will exclude critical values for microbiology, cardiac markers, drugs of abuse,
therapeutic drug levels, urinalysis, blood gases, point-of-care tests, tests performed at reference laboratories, and
critical values on discharged patients.
Total Critical Values Reporting Rate (%)

Inpatient Critical Values Reporting Rate (%)
Outpatient Critical Values Reporting Rate (%)
Turnaround Time of Troponin QT15
The swiftness with which physicians establish diagnoses of acute myocardial infarction (AMI) in patients presenting to
the emergency department (ED) with chest pain may determine the type and predict the outcomes of therapy
those patients will receive. Included in the total time consumed in establishing diagnoses of AMI are the component
intervals required to measure biochemical markers of myocardial injury. One of the most critical biochemical markers
is troponin. Help meet CAP Checklist question GEN.20316 with this monitor.
Objective
Determine the median order-to-report turnaround time (TAT) of troponin (I or T) and the percent of troponin results
reported by each institutions established deadline.
Data Collection
Participants will record TATs (in minutes) for three randomly selected troponin specimens obtained from patients seen
in EDs on each of three traditional shifts (total of nine measurements) on six predetermined days per month. They will
measure TATs from the time the tests are ordered to the time that results are made available to ED personnel.
Median Troponin Order-to-Report TAT (minutes)

Troponin TAT Compliance Rate (%)
Q-TRACKS
Corrected Results QT16
The CAP developed this Q-TRACKS monitor in recognition of the importance of timely detection and correction of
erroneous laboratory results. Accuracy in laboratory results is critical to the effectiveness of a physicians plan of care
for a patient. An erroneous result can delay or alter patient treatment; therefore, detection of erroneous results should
be a priority in every laboratory and should be monitored as a key quality indicator. Help measure your compliance
with CLIA 493.1299, Postanalytic Systems Quality Assessment, with this monitor.
Objective
Monitor the number of corrected test results within individual institutions and compare performance with that of all
institutions and those institutions similar to yours.
Data Collection
On a monthly basis, participants will monitor the number of corrected test results and the total number of billable tests
for that month. Include test results for all patients in all care settings with the following exclusions: anatomic pathology
tests, narrative physician-interpreted tests (ie, bone marrow biopsies and peripheral smear reports), and point-of-care
tests.
Test Result Correction Rate (per 10,000 billable tests)
Outpatient Order Entry Errors QT17
Order accuracy bears an obvious relationship to the quality of laboratory testing. When the laboratory fails to
complete a requested test, it delays the diagnostic evaluation, potentially extending a patients hospital stay and
prolonging therapy. When the laboratory completes a test that was not requested, the cost of care increases,
patients may be subjected to unnecessary phlebotomy, and laboratory efficiency declines.
Objective
Measure the incidence of incorrectly interpreted and entered outpatient physician test orders into the laboratory
computer, compare performance across institutions, and track performance over time.
Data Collection
On six preselected weekdays per month, participants will compare eight outpatient requisitions or order sheets to
the orders entered into the laboratorys information system to determine if any order entry errors occurred. Order
entry error categories include requesting physician errors; incorrect, missing, and extra test errors; test priority errors;
and nonroutine routing request errors. This monitor excludes tests performed in transfusion medicine/blood bank or
anatomic pathology. This monitor also excludes tests from the following patient care settings: inpatient, ED,
ambulatory surgery, urgent care, chest pain center, 23-hour short stay facility, employee health department,
outpatient screening fair/promotion, and dialysis center.
Outpatient Order Entry Error Rate (%)

Order Entry Error Rates by Type (%)
Breakdown of Error Types (%)
www.cap.org 13
Q-TRACKS
Specimen Acceptability in Blood Bank QT18
Appropriate collection and labeling of patient specimens are essential for accurate specimen analysis and reporting
of test results. Mislabeling of blood bank specimens can result in catastrophic outcomes when patients receive
incompatible red blood cells. Accrediting agencies, such as AABB and the CAP (TRM.30550, 30575), require
monitoring of key specimen quality issues and demonstration of a system for continual process improvement.
This Q-TRACKS monitor will allow you to compare your performance to your peers.
Objective
Identify and characterize incorrectly collected and labeled blood specimens submitted to the blood bank for testing.
Data Collection
On a weekly basis, participants will record the total number of specimens submitted to the blood bank and the
number of rejected specimens. Participants will also report the primary reason for specimen rejection based on the
following categories:
Wrong collection container
Specimen with any suitability
Requisition does not match specimen
Unlabeled specimen
concerns later reported by
Specimen hemolyzed
Incompletely labeled
caregivers
Specimen clotted
specimen
Other reason for rejection
Insufficient specimen volume
Mislabeled specimen
(ie, broken specimen)
Duplicate specimen
Participants will provide weekly numbers of ABO/Rh typing results discrepant from the historical record.
Specimen Rejection Rate (%)

ABO/Rh Discrepancy Rate (%)
Breakdown of Rejection Reasons (%)
Q-TRACKS
Q-TRACKS Anatomic Pathology Monitor
Gynecologic Cytology Outcomes: Biopsy Correlation Performance QT5
The correlation of cervicovaginal cytology (Pap test) findings with cervical biopsy results comprises a significant part
of the cytopathology laboratorys quality assurance program. By monitoring this correlation, the laboratory can
identify potential problems that require improvement, thereby ensuring better patient results.
Objective
Quantify the correlation between the findings of cervicovaginal cytology and corresponding histologic material.
Data Collection
On a monthly basis, participants will record information on true-positive, false-positive, and false-negative
cytology-biopsy correlations. The false-negative correlations will be classified into four error categories: screening
errors, interpretive errors, screening and interpretive errors, and adequacy determination errors. Participants will also
record the biopsy diagnoses for Pap tests with an interpretation of atypical squamous cells (ASC-US and ASC-H) or
atypical glandular cells (AGC). This monitor includes patients for whom a cervical biopsy specimen is submitted to
the laboratory and for whom a satisfactory or satisfactory but limited Pap test has been submitted within three
months previous to the biopsy or at the time of the biopsy.
Predictive Value of Positive Cytology (%)

Sensitivity (%)
Screening/Interpretation Sensitivity (%)
Sampling Sensitivity (%)
Percent Positive for ASC-US Interpretations
Percent Positive for ASC-H Interpretations
Percent Positive for AGC Interpretations
www.cap.org 15
LMIP
LMIP
Laboratory Management Index Program
Manage your laboratory more effectively with LMIP The Laboratory Management
Index Program (LMIP), an effective fiscal management tool, offers a valuable peer
comparison of your laboratorys performance. LMIP can help you with the annual
budget process, contract negotiations, and daily operations management.
With more than 10 years of experience and the largest laboratory participant
database, LMIP is the best management resource for health care professionals
charged with decision-making responsibilities. Using management ratios as
performance indicators, LMIP extends beyond traditional analysis of productivity
and staffing to focus on the most important factors affecting laboratory
performance:
Productivity How effectively are you using your laboratory personnel?
Utilization How do your test-ordering patterns compare to those of your

peers?
Cost-effectiveness How efficiently are you using your supplies, equipment,

and labor?
With LMIPs statistically valid method of peer grouping (fingerprint clustering), you
receive the most meaningful comparisons. These comparisons allow you, your
colleagues, and your administration to make informed and realistic decisions about
staffing, budgets, and other performance targets.
Achieving quality test results involves more than just ensuring properly conducted
tests. Understanding financial factors that drive laboratory processes enhances your
confidence in the management decisions you make. Ultimately, these decisions will
guide your organization to deliver superior patient care.
LMIP
Laboratory Management Index Program LMB
LMIP provides a report of your laboratorys overall operation. Quarterly reports summarize relevant management
ratios that provide analysis of the productivity of personnel, laboratory policies and procedures, salary and other
expenses, physician test utilization, and organizational benefits.
The input items you will collect include:
Blood Expense
Consumable Expense
Outpatient Visits
Referred SBTs
Equipment Depreciation Expense
Referred SBT Expense
Hospital Inpatient Days
Testing Paid Hours
Equipment Maintenance and Repair Expense

Hospital Inpatient Discharges
Inpatient SBTs
Nonpatient SBTs
On-Site SBTs
Outpatient SBTs
Testing Labor Expense
Total Labor Expense
Total Laboratory Paid Hours
Total Laboratory Worked Hours
Total SBTs
LMIP uses the Standardized Billable Test (SBT) as the primary unit of measure. The SBT standardizes test counts and
eliminates billing, accounting, and interpretation variations to ensure valid comparisons.
www.cap.org 17
CAP LINKS
CAP LINKS
The Integrated Knowledge Source
Consolidate proficiency testing, accreditation, and quality improvement

data for your entire organization into concise and actionable reports.
The CAP designed CAP LINKS for multihospital systems, academic medical centers
with numerous testing locations, and national commercial reference laboratories.
CAP LINKS provides a high-level overview useful in identifying improvement
opportunities and demonstrating good QI performance. You can access CAP LINKS
data directly from the CAP laboratory improvement database. Therefore, the CAP
does not require additional data submission. Use CAP LINKS for all of your CAP
laboratory improvement programs, including:
Surveys & Anatomic Pathology Education Programs and EXCEL
Laboratory Accreditation Program
Q-TRACKS Program
The enchanced CAP LINKS provides you the ability to do the following:
Download data and manipulate reports to accommodate your specific

institutions needs
Use email to forward one or all reports to appropriate individuals for viewing
Designate viewing options to select individuals directly via the CAP website
Receive CAP LINKS reports more promptly via the Webthe CAP will continue
to forward your printed reports via regular mail
Respond to exceptions in a more timely manner
The report package allows you to quickly see good performance and identify sites
that may require special attention, both at the laboratory level and at the system or
corporate level.
The CAP generates reports on a quarterly basis and distributes them by mail and via
the Internet to an individual whom you designate as your systems primary contact.
Annually, your primary contact will receive an overview of the systems full-year
performance for proficiency testing. Those individuals with granted viewing privileges
may view these secure online reports.
CAP LINKS
Quarterly reports summarize PT

systemwide average results by
discipline to allow for
interlaboratory comparisons.

325 Waukegan Road, Northfield, Illinois 60093-2750
800-323-4040 www.cap.org
Inspection Performance Overview by Laboratory

Laboratory Accreditation Program
Northwest Hospital System
23451-01 05/25/2001
Laboratory 1
Cambridge, MA
23455-01 05/25/2001
Laboratory 2
Johnston, RI
23478-01 08/16/2001
Laboratory 3
Pittsburg, PA
Note: Includes inspection deficiency information used in the most recent accreditation decision
Accreditation reports recap inspection findings for each laboratory.
www.cap.org 19
Quality Management Tools Pricing Overview
Quality Management Tools Pricing Overview

2011 Q-Probes
Modules/Package
Individual QP Studies
Product Codes
QP111, QP112, QP113, QP114
All Four QP Studies
Product Codes
Individual Anatomic Pathology (AP) Monitor
$940 each
QTP
$9,700
QT5
$940 each
QTC
$9,380
QTS
$4,988
2011 Laboratory Management Index Program

Product Code
LMIP
Combination Program Options
Option 1
Option 2
Option 3
Option 4
Individual Program Options
Laboratory Accreditation
Program
LMIP
Price
QT1, QT2, QT3, QT4, QT7, QT8,

QT10, QT15, QT16, QT17, QT18
Combined CP/AP Module Includes all 12 QT

Monitors
Clinical Pathology Module Includes all 11 CP
Monitors
Patient Safety Module Includes QT1, QT2, QT10,
QT15, QT16, QT17
Q-TRACKS
$1,424
2011 Q-TRACKS
Individual Clinical Pathology (CP) Monitors
Surveys/EXCEL
$395 each
PRO
Modules/Package
Module
Price
Price
LMB
2011 CAP LINKS
$820
Product Codes
Surveys/EXCEL
LAP
Q-TRACKS
LMIP
IMR2
IMR4
IMR1
IMR3
IMRPT
IMRLP
IMRQT
IMRLM
Price
$2,800
$2,000
$2,200
$1,500
$1,500
$800
$500
$500
Tools to Help You

Manage Your Workload
n

SM
Alerts you that your proficiency testing (PT) products
have shipped
n Allows you to track your shipment through a link
n Results in less worries
Provides access to your time-critical evaluation of
Linearity Reports within two business days of data

submission through e-LAB SolutionsTM
Saves valuable time, getting you results up to 10 days
sooner
n Minimizes PT failure with prepopulated electronic
forms and drop-down menus
n Eliminates clerical errors due to scanning or faxing
n Manages your workload with timely email reminders
for data submission and result reporting
Provides ongoing information about all divisions of
the College of American Pathologists (CAP)

n Offers periodic updates available for review on the
CAP website by selecting the Accreditation and
Laboratory Improvement tab
Provides regulatory and other important information
relative to CAPproducts and services

n Contains time-sensitive information for laboratories
TM
325 Waukegan Road

Northfield, IL 60093-2750
Programs and Resources

Accreditation
Offers the gold standard for laboratory
accreditation
Efficiency/Quality Tools
Allows more time for patient care
Proficiency Testing
Ensures precision and confidence for your
laboratory
Advocacy
Represents the interests of pathologists in the
government and regulatory arenas and in the
private sector
CAP 15189SM
Recognizes a sustainable Quality Management
System
Membership
Provides valuable benefits and leadership for all
laboratory professionals
Education
Serves as a leading resource for information and
education in the laboratory
SNOMED Terminology Solutions (STS)

Offers consultation and education services to
transform health information
17.2M/710/40996-2

2011 QMT Catalog

Загружено:

Сведения о документе

Оригинальное название

Авторское право

Доступные форматы

Поделиться этим документом

Поделиться или встроить документ

Параметры публикации

Этот документ был вам полезен?

Это неприемлемый материал?

Авторское право:

Доступные форматы

2011 QMT Catalog

Загружено:

Авторское право:

Доступные форматы

TM

Quality Management Tools

Approved for Maintenance of Certification

Quality Management Tools

Q-TRACKS Continuous Quality Monitoring Program

LMIP Laboratory Management Index Program

CAP LINKS The Laboratory Integrated Knowledge Source

Identify quality improvement opportunities and monitor progress over time

2011 Quality Management Tools

Q-PROBES and Q-TRACKS

Select Q-PROBES and

offer a comprehensive collection of tools to

Laboratory Services for Emergency

Patient Identification Accuracy (QT1)

In-Date Blood Product Wastage (QT4)

Laboratory Specimen Acceptability (QT3)

Critical Values Reporting (QT10)

Corrected Results (QT16)

Outpatient Order Entry Errors (QT17)

Turnaround Time of Troponin (QT15)

2 800-323-4040 Option 1 for Customer Contact Center

College of American Pathologists

A Program for In-depth Comprehensive Assessment

Examine the effectiveness of key processes

2011 Quality Management Tools

Laboratory Services for Emergency Department QP111

o Order-to-report TATs for creatinine, CBC, and microscopic urinalysis

o Satisfaction of ED physicians with clinical laboratory services

This is a one-time study conducted in the first quarter.

4 800-323-4040 Option 1 for Customer Contact Center

Appropriateness of Plasma Transfusions QP112

o Rate of plasma transfusions that met institutional guidelines

o Rate of plasma units prepared but not transfused

This is a one-time study conducted in the second quarter.

2011 Quality Management Tools

Surgical Pathology Report Defects QP113

Rate of surgical pathology report defects

Breakdown of surgical pathology report defect reasons:

This is a one-time study conducted in the third quarter.

6 800-323-4040 Option 1 for Customer Contact Center

College of American Pathologists

Clinical Consequences of Specimen Rejection QP114

o Percentage of rejected chemistry and hematology blood specimens

Breakdown of rejection reason for the two groups:

This is a one-time study conducted in the fourth quarter.

2011 Quality Management Tools

A Program of Continuous Quality Monitoring

Establish realistic benchmarks by comparing

Identify improvement opportunities.

(most like you)

Q-TRACKS: QT3 - Laboratory Specimen Acceptability

Monitor improvement over time to

8 800-323-4040 Option 1 for Customer Contact Center

College of American Pathologists

Q-TRACKS Clinical Pathology Monitors

Patient Identification Accuracy QT1

Wristband Error Rate (%)

Breakdown of Wristband Error Types (%)

Blood Culture Contamination QT2

Neonatal Contamination Rate (%)

2011 Quality Management Tools

Laboratory Specimen Acceptability QT3

Specimen Rejection Rate (%)